Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series

Therapy for leptomeningeal metastases (LM) from non-small cell lung cancer (NSCLC) is challenging, and conventional treatments have little impact on the disease course. We report three cases that were definitively diagnosed as LM from NSCLC with a mutation of epidermal growth factor receptor (EGFR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiying, Yu, Tingting, Huang, Mingmin, Guo, Aibin, Qian, Xiaoping, Yin, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759207/
https://www.ncbi.nlm.nih.gov/pubmed/31571928
http://dx.doi.org/10.2147/OTT.S199452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759207/
https://www.ncbi.nlm.nih.gov/pubmed/31571928
http://dx.doi.org/10.2147/OTT.S199452

Ejemplares similares